Friction-free access to diverse LTC patients. We treat, engage, and capture real-world evidence in one pathway.

Woodlands Medical Practice
Previously, it was a struggle to review all our patients who needed medications up-titrated. With Suvera, we now have a solution that provides extra support to those who need it most, while also easing pressure on practice clinicians. Patients are giving great feedback, engaging well with the virtual clinic and we’re seeing great outcomes.”
South Central Ealing PCN
It was a pleasure to work with Suvera clinicians who delivered care plans for our patients with severe frailty. The reviews were very comprehensive and enabled health and social needs to be identified and action plans implemented to improve patient wellbeing. Suvera were well received by our patients. We would not hesitate to work with them again.
Enfield South West PCN
Suvera were easy to engage with, understanding our needs and ways of working. The induction process was well organised and easy to follow, and they are extremely responsive to any queries or issues. We are now extending our work with them to cover type 2 diabetic patients and patients with raised cholesterol in high-risk groups/QOF cohorts.
Half Penny Steps
Suvera is an exceptional clinical service that enhances our long-term condition registers. Our patients are well cared for and consistently provide positive feedback. With Suvera, we're surpassing core performance indicator targets. I confidently recommend it to practices looking to boost clinical capacity and improve healthcare quality.
Acton PCN
The team at Suvera have been a pleasure to work alongside. In addition to exceeding expectations, they genuinely care about the patient journey, building relationships and improving patient care. They have taken feedback given onboard when needed. I would be happy to recommend working with them and their team.
Shrewsbury PCN
I would have no hesitation recommending Suvera to other practices and PCNs. They're a great team they're really friendly they're really approachable, and if you're thinking about a different way of approaching your chronic disease management then they are just a fantastic solution.
Suvera is a CQC-registered virtual clinic embedded across 23+ NHS Integrated Care Boards, managing over 100,000 patients with long-term conditions.
We provide complete clinical delivery - patient identification, remote monitoring, medication reviews, medication optimisation and ongoing care - freeing practice capacity while improving outcomes. Our service combines NHS-trained clinicians with integrated technology, delivering proactive care at population scale.
Our Virtual Clinic operates as a trusted extension of general practice, managing patients with conditions like hypertension, diabetes, COPD, and heart failure. For life sciences partners, this creates a direct market access to appropriate patient populations within NHS governance.
We identify eligible patients, conduct clinical assessments, initiate suitable medications and therapies following NICE guidelines, and monitor outcomes - all within our existing clinical infrastructure.
Suvera manages long-term health conditions including cardiovascular conditions (hypertension, cholesterol, heart failure), diabetes and obesity (Type 2 diabetes, insulin management, GLP-1), respiratory (asthma, COPD), renal (chronic kidney disease), frailty, and structured medication reviews.
Our clinical team includes clinical pharmacists and physicians specialising in these areas, ensuring condition-specific expertise across all pathways.
Suvera's patient recall platform analyses patient data from EMIS and SystmOne, identifying individuals based on clinical criteria - risk stratification, test results, current medications, and treatment gaps.
This allows precise cohort identification for specific therapies. Our clinical team then reviews eligibility according to NICE guidelines and local protocols before any treatment discussion occurs with patients.
Life sciences real world evidence generation captures how treatments perform in routine NHS practice. Suvera automatically collects structured, longitudinal data - treatment initiation, adherence, outcomes, patient-reported measures - across diverse populations.
This creates robust datasets for regulatory submissions, health economics, and treatment optimisation. We are able to view impact at a demographic level ensuring equity and access are at the heart of modern primary care delivery.
All prescribing follows NICE guidelines and NHS protocols, decided by Suvera's independent clinical team.
Pharmaceutical patient programs operate under strict governance aligned with the ABPI code of conduct - partners access aggregate data and appropriate cohorts, but clinical decisions remain with qualified clinicians. CQC registration and NHS partnerships depend on maintaining this independence.
Suvera's virtual clinic manages 100,000+ patients across cardiovascular, diabetes, respiratory, renal, and frailty pathways.
Life sciences patient access partners reach clinically appropriate cohorts identified through our software - patients meeting eligibility criteria who would benefit from specific therapies. We typically see 91% patient engagement across all demographics, including high-deprivation areas, providing genuinely diverse real-world cohorts.
We only obtain explicit patient consent for anonymised data use in pharmaceutical research. Life sciences partners receive aggregate, de-identified datasets only - no individual patient information. Data sharing agreements specify permitted uses, conform to NHS Digital standards, and undergo information governance review. CQC registration and NHS contracts require these protections. Pharmaceutical market access means access to evidence, not identifiable patient data.